SynthesisAdvances in therapy2026

Evidence-Based Positioning of Sodium-Glucose Co-transporter 2 Inhibitors and Glucagon-Like Peptide 1 Receptor Agonists in the Management of Chronic Kidney Disease with Type 2 Diabetes and Overweight or Obesity: A Systematic Literature Review.

Yehuda Handelsman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.